Posters
« Back
Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan. POSTER # 722,  62nd ASMS Conference on Mass Spectrometry and Allied Topics June 15 - 19, 2014 - Baltimore Convention Center
EP22067
Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan. POSTER # 722, 62nd ASMS Conference on Mass Spectrometry and Allied Topics June 15 - 19, 2014 - Baltimore Convention Center
Submitted on 09 Jul 2014

Ningombam Sanjib Meitei(1); Arun Apte*(2); Sergei Snovida(3); Julian Saba(4); John Rogers(3)
(1)PREMIER Biosoft, Indore, India; (2)PREMIER Biosoft, Palo Alto, CA, USA; (3)Thermo Fisher Scientific, Rockford, IL, USA; (4)Thermo Fisher Scientific, San Jose, CA, USA Presented at
This poster was presented at 62nd ASMS Conference on Mass Spectrometry and Allied Topics
Poster Views: 1,796
View poster »
Poster Abstract
Introduction

One of the emerging trends in glycomics research is the innovation related to accurate MS based quantitative analysis of glycans. Recently, we have introduced aminoxyTMT Reagents, which enable efficient relative quantitation of carbohydrates, improved labeled-glycan ionization efficiency and increased analytical throughput. These reagents can be used for quantitative analysis of native N-glycans by direct or LC-coupled ESI-MS. However, unlike for proteomics, one of the major challenges left unaddressed is the lack of informatics tools to automate the qualitative and quantitative analysis protocols. These protocols include identification/quantitation of glycans using MS/MS data and differential analysis across biological samples. SimGlycan software is redesigned to streamline such protocols of the quantitation of labeled-glycoforms derived from complex mixtures.

Methods

Tryptic digests of several standard glycoproteins and monoclonal antibodies were treated with PNGase F glycosidase to release N-glycans. Following reversed-phase and graphitized carbon extraction/desalting steps, the glycans were labeled with oxyTMT reagents according to an optimized protocol. Labeled glycans were analysed using Velos Pro mass spectrometer (Thermo Scientific) in the positive ion mode to acquire trap-HCD MS/MS fragmentation. Data was subjected to SimGlycan to identify structure of the sample glycans. Post identification, we assign TMT 130.13 ion as the control The program allows custom setting of reporter ions correction factors, calculates sum/average/median of the reporter ion intensities, number of MS/MS spectra which identifies a glycan. Different types of chart facilitate glycan differential analysis across samples.

Preliminary Results/Abstract

TMT reporter ion peak cluster was one of the most intense features in the MS2 spectra for all doubly-charged precursors that contained one sodium and one proton adduct. In order to test the performance of the software, HCD spectra were acquired on five high-mannose glycans. HCD fragmentation of high-mannose glycan precursors viz. 780, 861, 942, 1023 and 1124 m/z produced abundant TMT reporter ions, as well as Y/B/A-type ions. The MS/MS data was subjected to SimGlycan for structural identification. The program identifies N-glycan with carbohydrate residues (GlcNAc)2(Man)5 for the precursor m/z value 780, N-glycan (GlcNAc)2(Man)6 for 861, N-glycan (GlcNAc)2(Man)7 for 942, N-glycan (GlcNAc)2(Man)8 for 1023 and N-glycan with (GlcNAc)2(Man)9 for 1124, which is a correct assignment for all high-mannose glycans present in the sample. Majority of the ions with intact TMT tag carry Na adduct and are generally the outcome of two glycosidic cleavages towards reducing end. The program enables the quantitation by measuring reporter ion peak intensities. In order to nullify the interference of other nearby peaks onto TMT reporter ions, we set a custom correction factor. Statistics calculated as a measure of the relative amount/expression level of each glycan present in the samples constitute sum/average/median/standard deviation of the reporter ion intensities, ratio sum/average/median intensity of each TMT ion and the control TMT 130.13 ion, Log2 relative expressions of these ratios, number of MS/MS spectra which identifies each glycan. Differential analysis and data visualization are facilitated through different charts. Heat map displays relative intensities of TMT reporter ions for each identified glycan. Cluster dot plot shows Log2 expression levels of a glycan at different TMT reporter ions. The performance of the software for several standard glycoproteins and monoclonal antibodies were also examined in these studies.

1. Gong, B., Hoyt, et al. (2013). N-Glycosylamine-mediated isotope labeling for mass spectrometry-based quantitative analysis of N-linked glycans.
Analytical and bioanalytical chemistry, 405(17), 5825-5831.
2. Yang, Shuang, et al. (2013). Glycan Analysis by Isobaric Aldehyde Reactive Tags and Mass Spectrometry. Analytical chemistry 85(17) :
8188-8195.
3. Viner, R. I., et al (2010). A Novel Workflow for Glycopeptide Analysis Using Cellulose-Based Separation Cartridges, TMT-Labelin
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


MODEL-AD: Bioinformatics and Data ManagementMODEL-AD: Bioinformatics and Data Management
Bruce Lamb1, Michael Sasner2, Andrew Saykin1, Lara Mangravite3, Gregory Carter2

MODEL-AD: The Disease Modeling Project
M.Sasner1, A. Oblak2, H. Williams1, G. Howell1, B.T. Lamb2 and the MODEL-AD consortium

MODEL-AD: Genetic models of late-onset Alzheimer’s disease
*A. OBLAK1,2, G. CARTER3, G. R. HOWELL3, B. LOGSDON4, L. MANGRAVITE4, K. NHO2, L. OMBERG4, K. D. ONOS3, V. PHILIP3, C. PREUSS3, S. J. SUKOFF RIZZO3, M. SASNER3, L. SHEN1,2, A. J. SAYKIN1,2, P. TERRITO1,2, A. UYAR3, H. WILLIAMS3, B. T. LAMB1,5

Preclinical drug screening in new generation Alzheimer’s disease mouse models: The MODEL-AD Consortium Strategy
P.R. Territo1, S.J. Sukoff Rizzo2, K. Onos2, J.A. Meyer1, J. Peters1, S.C. Persohn1, B.R. McCarthy1, A.A. Riley1, S. Quinney1, D. Jones1, M. Sasner2, G. Howell2, H. Williams2, A.J. Oblak1, B.L. Lamb1 and the MODEL-AD consortium

Extracorporeal Shock Wave Therapy in situ – a novel approach to obtain an activated fat graft
Priglinger Eleni1,2, Peterbauer Anja2,3, Wurzer Christoph1,2,4, Steffenhagen Carolin1,2, Redl Heinz1,2,4, Sandhofer Matthias5, Wolbank Susanne 1,2